Q2 2026 Strategic Insights Executive Summary
Exclusive quarterly market intelligence for Qsight customers.
The Q2 2026 Strategic Insights Executive Summary provides a high level view of performance across the U.S. medical aesthetics market, highlighting quarterly trends, market shifts, and strategic takeaways across key treatment categories.
This customer exclusive executive summary includes insights covering:
- Overall aesthetics market performance
- Injectables
- Energy-Based Devices (EBD)
- Skin Rejuvenation (Non-EBD)
- Professional Grade Skincare